Considerations for payers in managing hormone receptor-positive advanced breast cancer
Mona Chitre,1 Kristen M Reimers21Pharmacy Management, Excellus BlueCross BlueShield, Rochester, NY, USA; 2Clinical Drug Programs, Magellan Health/Icore, Orlando, FL, USAAbstract: Breast cancer (BC) is the second most common cause of death in women. In 2010, the direct cost associated with BC care i...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-07-01
|
| Series: | ClinicoEconomics and Outcomes Research |
| Online Access: | http://www.dovepress.com/considerations-for-payers-in-managing-hormone-receptor-positive-advanc-a17547 |